Literature DB >> 6360277

Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

J R Vane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6360277      PMCID： PMC2044916          DOI： 10.1111/j.1476-5381.1983.tb10020.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  125 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol.

Authors:  A M BOYD; J MARKS
Journal:  Angiology       Date:  1963-04       Impact factor: 3.619

3.  Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

Authors:  J GLAVIND; S HARTMANN; J CLEMMESEN; K E JESSEN; H DAM
Journal:  Acta Pathol Microbiol Scand       Date:  1952

4.  The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings].

Authors:  S Bunting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

5.  Prostacyclin reduces the number of 'slow moving' leucocytes in hamster cheek pouch venules [proceedings].

Authors:  G A Higgs; S Moncada; J R Vane
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

6.  Inhibition of polymorphonuclear leukocyte adherence by prostacyclin.

Authors:  L A Boxer; J M Allen; M Schmidt; M Yoder; R L Baehner
Journal:  J Lab Clin Med       Date:  1980-05

7.  The effect of infused prostacyclin in migraine and cluster headache.

Authors:  R C Peatfield; M J Gawel; F C Rose
Journal:  Headache       Date:  1981-09       Impact factor: 5.887

8.  Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation.

Authors:  J W Aiken; R R Gorman; R J Shebuski
Journal:  Prostaglandins       Date:  1979-04

9.  Prostacyclin therapy in patients with congestive heart failure.

Authors:  Y Yui; H Nakajima; C Kawai; T Murakami
Journal:  Am J Cardiol       Date:  1982-08       Impact factor: 2.778

10.  Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

Authors:  M Minkes; N Stanford; M M Chi; G J Roth; A Raz; P Needleman; P W Majerus
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808
View more
  7 in total

1.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

2.  Experimental cerebral vasospasm: resolution by iloprost.

Authors:  N Egemen; K Birler; N Avman; R K Türker
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

3.  Modulation by endothelium of the vascular effects of angiotensin II.

Authors:  G Yilmaz; H E Aksulu; E Demirel; Z S Ercan; H Zengil; R K Türker
Journal:  Agents Actions       Date:  1987-06

4.  Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.

Authors:  R A Keith; A I Salama
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

Review 5.  Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.

Authors:  Scott Gleim; Zsolt Kasza; Kathleen Martin; John Hwa
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 6.  Resolution of Inflammation: What Controls Its Onset?

Authors:  Michelle A Sugimoto; Lirlândia P Sousa; Vanessa Pinho; Mauro Perretti; Mauro M Teixeira
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

Review 7.  Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.

Authors:  Sean X Gu; Tarun Tyagi; Kanika Jain; Vivian W Gu; Seung Hee Lee; Jonathan M Hwa; Jennifer M Kwan; Diane S Krause; Alfred I Lee; Stephanie Halene; Kathleen A Martin; Hyung J Chun; John Hwa
Journal:  Nat Rev Cardiol       Date:  2020-11-19       Impact factor: 32.419
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.